MMIT and The Dedham Group have united to offer premier advisory services to oncology clients.
Amid an increasingly crowded oncology marketplace, pharma companies are looking for trusted advisors to help them navigate the complex path to market access. By partnering with The Dedham Group, a preeminent market access consulting firm in the oncology and specialty therapeutics spaces, MMIT can further our mission to help smooth access to therapy.
Key offerings include:
Why Pharma Needs to Redefine its Role With IDNs As IDNs continue to expand their reach and influence, it’s time for pharma companies to rethink their one-size-fits-all approach to IDN engagement. Here’s how.READ FULL ARTICLE